WENDY CHEN
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology ORO VALLEY, AZ NPI 1659317469
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology AZ Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$1,294.00
- Category: General Payments
- Program years: PY2018–2024
- Record count: 57
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,215.86 across 51 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,215.86 | 51 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $255.04 | 10 |
| Acerta Pharma LLC | $176.15 | 5 |
| Bayer HealthCare Pharmaceuticals Inc. | $112.39 | 6 |
| Genmab U.S., Inc. | $92.88 | 3 |
| PFIZER INC. | $90.24 | 4 |
| GENZYME CORPORATION | $66.66 | 2 |
| PharmaEssentia USA Corporation | $61.47 | 3 |
| SOBI, INC | $45.91 | 2 |
| Karyopharm Therapeutics Inc. | $44.49 | 2 |
| GlaxoSmithKline, LLC. | $44.16 | 2 |
| Daiichi Sankyo Inc. | $39.89 | 2 |
| Alexion Pharmaceuticals, Inc. | $34.73 | 2 |
| Octapharma USA, Inc. | $22.98 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.31 | 1 |
| Teva Pharmaceuticals USA, Inc. | $21.16 | 1 |
| BeiGene USA, Inc. | $20.54 | 1 |
| Stemline Therapeutics Inc. | $17.21 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.50 | 1 |
| Adaptive Biotechnologies Corporation | $16.30 | 1 |
| Incyte Corporation | $14.85 | 1 |
By program year
Records — PY2024 (51)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.